ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.52M | 693K | 743K | 1.05M | 2.48M | 4.56M | 1.45M | 4.57M | 8.98M | 3.85M | 6.15M | 11.49M | 15.41M | 22.77M | 29.24M | 40.16M | 896K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -367K | -367K | -162K | -615K | -615K | n/a |
Other Long-Term Assets | 29K | 29K | 29K | 29K | 29K | 29K | 29K | 57K | 57K | 46K | 1.22M | 931K | 1.38M | 1.46M | 1.53M | 1.63M | 46K |
Receivables | 761K | 987K | 1.34M | 1.38M | 1.57M | 1.66M | 2.15M | 1.98M | 2.13M | 2.18M | 2.23M | 2.45M | 2.41M | 2.81M | 3.46M | 3.42M | 3.37M |
Inventory | 2.53M | 2.46M | 2.93M | 3.25M | 3.47M | 3.74M | 3.2M | 3.27M | 3.49M | 3.61M | 4.17M | 4.23M | 4M | 3M | 3.21M | 2.89M | 2.1M |
Other Current Assets | 400K | 114K | 156K | 162K | 180K | 239K | 232K | 281K | 360K | 184K | 257K | 247K | 265K | 238K | 397K | 18.01M | 1.29M |
Total Current Assets | 6.29M | 4.59M | 5.34M | 6.09M | 7.89M | 10.3M | 7.4M | 10.54M | 15.23M | 9.91M | 13.57M | 19.49M | 23.63M | 30.25M | 37.59M | 65.61M | 8.25M |
Property-Plant & Equipment | 133K | 154K | 220K | 250K | 280K | 310K | 344K | 956K | 758K | 869K | 1.15M | 1.23M | 1.9M | 1.72M | 2.05M | 2.22M | 1.11M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 238K | 249K | 260K | 12.51M | 19.91M | 20.37M | 20.83M | 49.52M | 50.55M | 26.61M |
Total Long-Term Assets | 188K | 205K | 277K | 306K | 336K | 431K | 428K | 1.31M | 1.12M | 1.23M | 14.88M | 22.44M | 23.64M | 24M | 53.11M | 54.4M | 27.77M |
Total Assets | 6.48M | 4.79M | 5.62M | 6.39M | 8.23M | 10.73M | 7.83M | 11.85M | 16.35M | 11.14M | 28.46M | 41.92M | 47.27M | 54.26M | 90.7M | 120M | 36.02M |
Account Payables | 1.69M | 2.21M | 2.1M | 1.03M | 1.31M | 1.69M | 1.46M | 1.6M | 2M | 1.93M | 1.99M | 2.51M | 3.6M | 3.47M | 3.11M | 3.1M | 3.64M |
Deferred Revenue | 838K | n/a | n/a | 318K | 643K | 639K | 657K | 459K | 573K | 510K | 644K | 605K | 596K | 549K | 580K | 518K | 397K |
Short-Term Debt | n/a | 811K | n/a | n/a | n/a | 111K | 110K | 109K | 86K | n/a | 255K | 338K | 441K | n/a | 3.44M | 3.6M | n/a |
Other Current Liabilities | 210K | 1.82M | 1.76M | 991K | 1.49M | 1.17M | 1.77M | 1.44M | 3.78M | 3.56M | 2.48M | 3.64M | 3.08M | 1.75M | 2.07M | 43.8M | 14.73M |
Total Current Liabilities | 4.12M | 4.99M | 4.03M | 3.2M | 3.52M | 3.78M | 4.47M | 4.4M | 7.6M | 7.48M | 7.51M | 9.19M | 8.15M | 7.33M | 10.34M | 60.5M | 21.63M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.12M | 61K | 26K | 54K | 51K | 72K | 100K | 512K | 992K | -123K | n/a | 5K | 41K | 300K | 527K | 770K | 1.59M |
Total Long-Term Liabilities | 1.13M | 61K | 103K | 157K | 178K | 287K | 275K | 710K | 992K | 2.61M | n/a | 372K | 494K | 855K | 1.14M | 1.39M | 1.68M |
Total Liabilities | 5.25M | 5.05M | 4.13M | 3.36M | 3.7M | 4.06M | 4.74M | 5.11M | 8.59M | 7.48M | 7.51M | 9.56M | 8.64M | 8.19M | 11.48M | 61.88M | 23.31M |
Total Debt | 130K | 967K | 191K | 216K | 239K | 262K | 285K | 307K | 86K | 171K | 255K | 338K | 527K | 279K | 3.44M | 3.6M | 402K |
Common Stock | n/a | n/a | n/a | 29K | 23K | 23K | 3K | 3K | 3K | 1K | 23K | 20K | 19K | 18K | 18K | 8K | 6K |
Retained Earnings | -641.23M | -642.7M | -640.94M | -639.36M | -637.77M | -635.57M | -633.88M | -630.34M | -626.85M | -624.19M | -606.36M | -594.55M | -584.98M | -576.76M | -541.3M | -523.6M | -519.7M |
Comprehensive Income | -110K | -104K | -88K | -89K | -96K | -88K | -94K | -95K | -93K | -88K | -68K | -72K | -71K | -92K | -107K | -109K | -102K |
Shareholders Equity | 1.23M | -253K | 1.49M | 3.04M | 4.53M | 6.66M | 3.08M | 6.74M | 7.76M | 3.66M | 20.94M | 32.36M | 38.63M | 46.07M | 79.22M | 58.12M | 12.71M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -367K | -162K | -615K | -615K | n/a |